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It is well established that ligand-gated chloride flux
across the plasma membrane modulates neuronal
excitability. We find that a voltage-dependent Cl2 con-
ductance increases neuronal excitability in immature
rodents as well, enhancing the time course of NMDA
receptor-mediated miniature excitatory postsynaptic
potentials (mEPSPs). This Cl2 conductance is acti-
vated by CaMKII, is electrophysiologically identical
to the CaMKII-activated CLC-3 conductance in non-
neuronal cells, and is absent in clc-32/2mice. System-
atically decreasing [Cl2]i to mimic postnatal [Cl
2]i reg-
ulation progressively decreases the amplitude and
decay time constant of spontaneous mEPSPs. This
Cl2-dependent change in synaptic strength is absent
in clc-32/2mice. Using surface biotinylation, immuno-
histochemistry, electron microscopy, and coimmuno-
precipitation studies, we find that CLC-3 channels are
localized on the plasma membrane, at postsynaptic
sites, and in association with NMDA receptors. This
is the first demonstration that a voltage-dependent
chloride conductance modulates neuronal excitabil-
ity. By increasing postsynaptic potentials in a Cl2
dependent fashion, CLC-3 channels regulate neuronal
excitability postsynaptically in immature neurons.
Introduction
Chloride (Cl2) ion flux across the plasma membrane,
mediated by GABA- and glycine-activated Cl2 channels,
is an important modulator of neuronal excitability. Dur-
ing Cl2 channel activation, the net direction of Cl2 flux
and the functional consequence of activation depend
on the Cl2 equilibrium potential, determined by the intra-
cellular Cl2 concentration ([Cl2]i). In immature neurons,
[Cl2]i is high and the Cl
2 equilibrium potential is positive
to the resting potential, so that activation of GABA- or
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6 These authors share senior authorship.glycine-gated Cl2 conductances results in membrane
depolarization (Ben-Ari, 2002; Lu et al., 1999; Stein
et al., 2004). This Cl2 conductance-induced membrane
depolarization is sufficient to remove voltage-depen-
dent Mg2+ block of N-methyl-D-aspartate (NMDA)
receptors (Ben-Ari, 2002; Lu et al., 1999; Stein et al.,
2004) and increase intracellular calcium concentrations
([Ca2+]i), a potentially important trophic stimulus in
immature neurons. During postnatal development, up-
regulation of KCC2, the K+-Cl2 coupled cotransporter,
decreases [Cl2]i below its electrochemical equilibrium,
resulting in a hyperpolarizing shift in the Cl2 equilibrium
potential (Ben-Ari, 2002). Accordingly, activation of Cl2
channels in mature neurons results in membrane hyper-
polarization and decreased excitability.
In addition to ligand-gated anion conductances,
members of the extensive CLC anion channel family
have been identified within the central nervous system.
Of these channels, CLC-3 is ubiquitously expressed
throughout the central nervous system (Dickerson
et al., 2002; Stobrawa et al., 2001; Yoshikawa et al.,
2002). CLC-3, when expressed at the plasma mem-
brane, is unique among CLC channels, in that it is not
constitutively active. Instead, CLC-3 is activated by cal-
cium-calmodulin-dependent kinase II (CaMKII), which
phosphorylates its N terminus (Huang et al., 2001;
Robinson et al., 2004).
Presynaptically, CLC-3 has been localized to synaptic
vesicles, where it facilitates vesicular acidification prior
to vesicle fusion with the plasma membrane (Stobrawa
et al., 2001). The postsynaptic localization of CLC-3
has not been described. Here, we describe a CaMKII-
activated Cl2 conductance on the plasma membrane
of cultured immature mouse and rat hippocampal neu-
rons that is absent in clc-32/2 mice. This conductance
is activated synaptically by NMDA receptor-induced
[Ca2+]i increases. Immunohistochemical studies dem-
onstrate CLC-3 channel localization to the postsynaptic
plasma membrane and colocalization with NMDA recep-
tors. Comparison of synaptic activity from WT and
clc-32/2 neurons demonstrates that CLC-3 channels
enhance the time course of NMDA receptor-mediated
excitatory post synaptic potentials. Thus, by means of
Ca2+ signaling, CLC-3 plasma membrane channels en-
hance the efficacy of NMDA-activated synapses at early
times in postnatal neuronal development.
Results
Cultured Hippocampal Neurons Exhibit
a CaMKII-Activated Cl2 Conductance
Whole-cell current recordings were obtained from
hippocampal neurons cultured from P5 rats at 5–7
days in vitro. To clearly identify Cl2 current activation,
experiments were performed using solutions without
permeant cations, where Cl2 was the only permeant
species. Asymmetric solutions (40 mM Cl2 intracellular,
140 mM Cl2 extracellular) were used to reproduce the in-
tracellular Cl2 concentration of immature neurons (Ben-
Ari, 2002). Basal current was determined immediately
Neuron
322Figure 1. CaMKII Activates a Cl2 Current in
Hippocampal Neurons
(A) Representative voltage-clamp recording
of a P5 hippocampal rat neuron immediately
following establishment of whole-cell config-
uration (Basal) and following peak current
activation after diffusion of CaMKII into
the cell (CaMKII). Currents were elicited
during a series of test pulses from 2110 to
+110 mV in 10 mV increments from a holding
potential of 240 mV.
(B) Time course of current activation. Cells
were allowed to equilibrate for approximately
4 min prior to current recording. Diffusion of
the autonomously active CaMKII from the
pipette into the cell gradually activates a Cl2
current that plateaus at about 20 min.
(C) The averaged I-V relationship from all cells
examined (n = 31) shows significant outward
rectification, with the reversal potential about
216 mV.
(D) Summary of pharmacology of the CaMKII-
activated current. Cl2 current was not re-
corded in the absence of CaMKII in pipette
solution (n = 5). AIP (autoinhibitory peptide),
a specific CaMKII inhibitor, inhibited current
activation by CaMKII (n = 3) when included
in the pipette solution; BAPTA did not inhibit
the autonomous kinase-activated current
(n = 5), demonstrating that current activation
was not the result of Ca2+ release from inter-
nal stores.following whole-cell configuration and was negligible
(Figure 1A). Coincident with diffusion of the autonomous
kinase from the pipette into the neuron, test pulses in-
duced a voltage-dependent current whose amplitude
steadily increased over approximately 20–30 min
(Figure 1B). Maximal current density at 20 min with
a test pulse of +110 mV was 37.6 6 3.2 pA/pF (n = 31).
Without CaMKII in the pipette, test pulses induced no
current above basal levels. The current-voltage (I-V)
relationship of ICl, CaMKII was outwardly rectifying, with
a reversal potential of approximately 216 mV (Fig-
ure 1C). The difference between this potential and the
theoretic reversal potential for Cl2 under these ionic
conditions (231 mV) indicates some permeability of
the conductance to glutamate, used as a Cl2 substitute
in the internal pipette solution.
To confirm that the induced current was activated by
CaMKII, we added autoinhibitory peptide (AIP, 1 mM),
a specific CaMKII inhibitor (Ishida et al., 1995), to the pi-
pette solution along with the autonomous CaMKII. The
presence of AIP completely blocked activation of the
CaMKII-induced currents (n = 3). To exclude the possi-
bility that CaMKII indirectly activated this Cl2 channel
through release of Ca2+, we clamped [Ca2+]i with BAPTA
(10 mM) in the pipette solution and measured au-
tonomous kinase-induced Cl2 currents. The resultant
ICl, CaMKII amplitude (34.2 6 4.5 pA/pF, n = 5) was not
significantly different from that obtained when internal
free Ca2+ levels were buffered to 40 nM with 1mM
EGTA and 0.2 mM Ca2+ (Figure 1D).
The only previously reported CaMKII-activated con-
ductance at the molecular level is CLC-3, a member of
the CLC family of voltage-gated chloride channels,
which we have previously shown gives rise to outwardlyrectifying CaMKII-dependent Cl2 currents when ex-
pressed at the plasma membrane (Huang et al., 2001).
In addition to being activated by CaMKII, the anion con-
ductance in hippocampal neurons exhibited biophysical
properties identical to that of recombinant CLC-3, in-
cluding (1) an outwardly rectifying current-voltage rela-
tionship, (2) the identical halide anion selectivity series
(I2 > Cl2; see Figure S1 in the Supplemental Data avail-
able with this article online), and (3) inhibition of both in-
ward and outward CaMKII-activated currents by the Cl2
channel blocker DIDS (100 mM; percent inhibition, 75 6
10% at 110 mV; 52 6 9% at 2110mV, n = 3; Figure S1).
Thus, the biophysical signature of this anion conduc-
tance in hippocampal neurons was identical to that
exhibited by recombinant CLC-3.
Single CaMKII-Activated Channel Recordings Reveal
Two-Pore Activity
Members of the CLC chloride channel family are typified
by having a two-pore structure whereby each pore con-
ducts independently of the second pore and gating is
controlled by a mechanism involving both a fast and
slow gate (Ludewig et al., 1996, 1997; Middleton et al.,
1996; Miller, 1982). To assess whether the hippocampal
CaMKII-activated anion conductance demonstrated
two-pore behavior, we recorded activity of single
CaMKII-activated channels from inside-out patches
taken from P5 hippocampal rat neurons (Figure 2A). Cur-
rent recordings were obtained at potentials between
280 and +100 mV. Channels were activated by perfusing
the intracellular face of the patch with autonomous ki-
nase, using a pipette positioned 5–10 mm from the patch
pipette. In the presence of autonomous kinase, we con-
sistently observed two amplitudes of channel activity,
CLC-3 and Neuronal Excitability
323Figure 2. Single CaMKII-Activated Currents Recorded from Excised Inside-Out Patches from Rat P5 Hippocampal Neurons Exhibit Two-Pore
Behavior
(A) Diagram of perfusion configuration of inside-out patches.
(B) Top: Representative single-channel recordings of Cl2 current from an inside-out patch from a rat hippocampal neuron following activation by
autonomous CaMKII. The closed state is indicated by the letter C and the two open states are indicated as Pore 1 and Pore 2. Bottom: Time
course of CLC-3 activation following CaMKII application. Onset of perfusion is indicated by electrical transient.
(C) All points amplitude histograms of the current activity shown in (A). Channel activity under the three conditions was recorded at a holding
potential of +80 mV. Currents from the same patch were compared under (1) control (no autonomous CaMKII present) conditions, (2) following
activation of current with CaMKII, and (3) following exposure of the patch to CaMKII + AIP (1 mM) simultaneously.
(D) Average I-V relationship for single CaMKII-activated channel activity recorded from rat P5 hippocampal neuron inside-out patches.consistent with the activity of two pores, beginning
within 20 ms of CaMKII application (Figure 2B). All points
amplitude histograms of channel activity were con-
structed. In the absence of CaMKII, no channel activity
was observed (Figure 2C, top). In the presence of
CaMKII, equal open state probabilities were observed
for both pores, typical of CLC channels (Lin et al., 1999;
Nobile et al., 2000; Pusch et al., 2001; Saviane et al.,
1999; White and Miller, 1979). When the autoinhibitory
peptide (1 mM) was perfused onto patches with autono-
mous kinase, channel activity was absent (Figure 2C,
bottom). Current-voltage relationships for the two ampli-
tude peaks were constructed from data obtained from
four patches (Figure 2D): the conductance of the first
peak was 3.336 0.07 pS ; the conductance of the higher
peak was 6.53 6 0.22 pS, approximately double the
conductance of the first.
CaMKII-Activated Cl2 Currents Are Absent
in Hippocampal Neurons from clc-32/2 Mice
As described above, the CaMKII-activated anion
conductance we recorded in hippocampal neurons
exhibited the identical biophysical signature when com-
pared to the recombinant CLC-3 conductance. In order
to establish unequivocally that this conductance ismediated by CLC-3, investigators, unaware of the geno-
type of the cultured neurons, recorded CaMKII-acti-
vated anion conductances from hippocampal neurons
cultured from 5-day-old WT and clc-32/2 mice, using
techniques identical to those used to culture postnatal
rat neurons (Figure 3A). Resting membrane potential,
membrane time constant, input resistance, and mem-
brane capacitance did not differ between WT and
clc-32/2 neurons (Figure 3B). In neurons from WT
mice, Cl2 current was present in all neurons studied,
with current density ranging between 10 and 45 pA/pF,
(mean current density 22.6 6 3.9 pA/pF, n = 10). In
contrast, CaMKII-activated currents were absent in all
neurons from clc-32/2 mice (n = 11). These data confirm
that the CaMKII-activated anion conductance in hippo-
campal neurons is mediated by CLC-3 channels.
To understand the role played by the CaMKII-acti-
vated Cl2 conductance in regulating neuronal excitabil-
ity, we systematically altered ECl2, using intracellular so-
lutions of different Cl2 concentrations, and measured
the amplitude and time course of spontaneous miniature
excitatory synaptic potentials (mEPSPs) in the presence
of tetrodotoxin and picrotoxin. We chose Cl2 concentra-
tions to mimic the concentrations observed in immature
([Cl2]i 40 mM, ECl2 =231 mV) and mature neurons ([Cl
2]i
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324Figure 3. CaMKII-Activated Current Is Ab-
sent in clc-32/2 Cells
(A) Left: Western blot showing absence of
CLC-3 protein in membrane preparations
from clc-32/2 (knockout) mouse brain and
presence of CLC-3 in analogous preparations
from clc-3+/+ (WT). Middle: Representative
CaMKII activated currents recorded from
clc-32/2 and clc-3+/+ cultured mouse hippo-
campal neurons. Currents were recorded ac-
cording to the voltage protocol in Figure 1
and were recorded in the presence of auton-
omously active CaMKII (1 mg/ml) introduced
into the cell via the patch pipette. Right: Cur-
rent density comparison of CaMKII-mediated
Cl2 current activation in cultured clc-32/2 (0,
n = 11) versus WT (22.606 3.93, n = 10) hippo-
campal P5 neurons.
(B) Comparison of the basic membrane prop-
erties between WT and clc-32/2 cells. Upper
panel: voltage protocol, raw potential traces,
and V-I curve used to calculate membrane
parameters. Membrane potential was deter-
mined in perforated patch experiments. Input
resistance was determined from the ampli-
tude of a series of current injections. Resul-
tant voltages were plotted as a function of
current and the slope of the relationship
used to calculate the input resistance. Ca-
pacitance was determined from the time con-
stant of the decay of the capacity transient
and the value of the input resistance. Bottom
panel: Comparisons of membrane potential,
membrane time constant, input resistance,
and capacitance between neurons from WT
(black) and clc-32/2 mice (stippled). Mem-
brane potential (perforated patch) for WT
(55.34 6 1.62 mV, n = 5) and KO (52.38 6
2.33 mV, n = 8); membrane time constant
for WT (35.14 6 2.23 ms, n = 49) and KO
(33.92 6 3.89 ms, n = 28); membrane resis-
tance for WT (461 6 32 MU, n = 49) and KO
(4376 36 MU, n = 28); and membrane capac-
itance for WT (79.556 2.74 pF, n = 49) and KO
(75.27 6 4.51, n = 28).
(C) Averaged mEPSPs from single neurons in three different internal Cl concentrations from WT (black) and clc-32/2 (red) mice.
(D) Mean mEPSP amplitudes (D) and decay time constants (E) obtained in the same internal Cl2 concentrations as in (C), above, from WT (black)
and clc-32/2 (red) mice. Membrane potential was260 mV in all of the recording conditions. Error bars (6 SEM) for the mean data are within the
symbols.5 mM, ECl2 = 280 mV), as well as an intermediate con-
centration ([Cl2]i 20 mM, ECl2 = 249 mV; Figure 3C).
In neurons from WT mice, mEPSP amplitude in-
creased as a function of [Cl2]i: mean mEPSP amplitude
in neurons with 40 mM [Cl2]i (1.35 6 0.008 mV, n = 8541
mEPSPs in eight cells) was significantly greater (p <<
0.01) than in neurons with 5 mM [Cl2]i, (0.956 0.016 mV,
n = 2965 mEPSPs in eight cells). Similarly, the mean
decay time constant in neurons with 40 mM [Cl2]i
(29.17 6 3.74 ms, n = 8 cells) was significantly (p <
0.05) longer than the mean decay time constant in neu-
rons with 5 mM [Cl2]i (22.69 6 1.99 ms, n = 8 cells; Fig-
ure 3E). Thus, shifting ECl2 from280 mV to231 mV, typ-
ical of immature neurons, revealed that a voltage-gated
Cl2 current contributes a depolarizing stimulus to
spontaneous mEPSPs thereby increasing synaptic
excitability.
To assess whether CLC-3 mediates the ECl2-depen-
dent component of the mEPSP, we recorded mEPSPs
under identical [Cl2]i conditions in clc-3
2/2 neurons.In contrast to WT neurons, mEPSP amplitudes in
clc-32/2 neurons declined as a function of increasing
[Cl2]i (40 mM [Cl
2]i, 0.64 6 0.009 mV, n = 1007 mEPSPs
in 10 neurons; 5 mM [Cl2]i, 1.27 6 0.007 mV, n = 9588
mEPSPs in 23 neurons). In like fashion, the progressive,
[Cl2]i-dependent increase in decay time constant was
markedly attenuated in the clc-32/2 neurons (40 mM
[Cl2]i—19.68 6 0.93 ms, n = 10 neurons; 5 mM [Cl
2]i,
24.86 0.88 ms, n = 23 neurons). Thus, the voltage-gated
Cl2 conductance modulating the amplitude and time
course of spontaneous mEPSPs is CLC-3.
CLC-3 Currents Modulate Synaptically Evoked
NMDA Currents
The CaMKII dependence of CLC-3 activation predicts
that NMDA receptor-mediated EPSCs should contain
a Cl2 influx component due to activation of CLC-3.
Therefore, the EPSC reversal potential should lie nega-
tive to 0 mV and be sensitive to internal [Cl2]. Accord-
ingly, we evoked NMDA receptor currents in Mg2+-free
CLC-3 and Neuronal Excitability
325Figure 4. Current Voltage Curves for Isolated NMDA EPSCs in Cultured P5 Hippocampal Neurons Isolated from WT and CLC-32/2 Mice
(A) Comparison of single EPSCs at the voltage indicated from WT (black trace) and KO (red trace) cells. Currents were induced by brief (350 ms)
perfusion of NMDA (100 mM) and glycine (0.1 mM) from a perfusion pipette placed approximately 20 mm above the soma and delivered by a DAD-
12 drug perfusion system (Adams-List). The comparative voltage dependence of the EPSCs obtained from 17 WT and 5 KO cells with the SEM
(note some of the error bars fit within the points). Currents were obtained with internal Cl2 solutions that set ECl at 280 mV.
(B) EPSCs obtained in WT and KO cells in which in the internal Cl solutions set ECl at230. Currents were obtained in 8 WT and 11 clc-3
2/2 cells.
The external bath solution contained the following: NaCl 136, KCl 2.5, HEPES 10, D-glucose 10, CaCl2 2, MgCl2 1.3, tetrodotoxin 0.5 mM, and
picrotoxin 100 mM (pH 7.4). The pipette solution contained the following: KMeSO4 135, KCl 5, CaCl2 0.2, MgCl2 2, EGTA 0.05, HEPES 10, and
ATP-Mg 2 (pH 7.2) in the case where ECl was set at 280 mV. When ECl was set at 230 mV, the pipette solution contained 100 KMeSO4 and
40 KCl. Ca2+ in the pipette solutions was calculated to be 40 nM. Currents were corrected for liquid junction potentials.solutions in P5 cultured hippocampal neurons from WT
and clc-32/2mice at two different Cl2 equilibrium poten-
tials. Under conditions in which ECl2 =280 (internal [Cl
2]
set at 5 mM, reflecting the mature neuron, Figure 4A)
currents in the WT cells were decreased compared
with those observed in the KO cells throughout the volt-
age range. In addition, the current reversal potential for
the wild-type cells was shifted by218 mV relative to that
seen in the KO neurons. These data are consistent with
a model of mature neurons in which the activation of
CLC-3 is inhibitory and the contribution of the Cl2 con-
ductance underlying the NMDA conductance left shifts
the reversal potential.
In contrast, when ECl was set at231 mV (internal [Cl
2]
set at 40 mM), typical of immature neurons, the WT cur-
rent was consistently larger than the current in the clc-
32/2 neurons (Figure 4B). Consistent with the contribu-
tion of a Cl2 conductance, the reversal potential in the
WT neurons was left shifted compared with clc-32/2
neurons, but only by 7 mV. Thus, Ca2+ influx via
NMDARs activates CaMKII, leading to activation of the
CLC-3 channel and, in immature neurons, enhancing
membrane excitability.
CLC-3 Is Expressed at the Synaptic Plasma
Membrane in Hippocampal Neurons
Our recording of CLC-3 currents in hippocampal neu-
rons provides electrophysiological evidence that a pop-
ulation of CLC-3 localizes to the plasma membrane. We
verified plasma membrane expression biochemically inbiotinylation experiments. Using a membrane-imperme-
ant biotin derivative (NHS-LC-LC-Biotin), we biotiny-
lated plasma membrane proteins exposed on the extra-
cellular surface of cultured embryonic hippocampal
neurons. Upon cell lysis, biotinylated proteins were cap-
tured onto streptavidin-coated beads and separated by
SDS-PAGE, followed by Western blot analysis using
anti-CLC-3730–744. Incubation of the biotinylated pro-
teins with anti-CLC-3 revealed a band at 90 kDa, the pre-
dicted molecular weight for CLC-3. This band was not
seen in the eluate in the absence of biotinylation
(Figure 5A).
To obtain additional confirmation that CLC-3 localizes
to the plasma membrane, we assayed for CLC-3 expres-
sion in synaptic (synaptosomal) plasma membranes.
Because CLC-3 expression has been previously estab-
lished in synaptic vesicles (Stobrawa et al., 2001), we
separated synaptic vesicles from synaptosomal mem-
branes by lysing synaptosomes in hypotonic buffer
then purifying synaptic plasma membranes. As ex-
pected, CLC-3 expression was observed in isolated syn-
aptic vesicles, identified by synaptotagmin expression
(Figure 5B). The identity of synaptic plasma membranes
was confirmed with staining for ATPase a1; the absence
of contaminating synaptic vesicles in this preparation
was confirmed by the absence of synaptotagmin immu-
noreactivity. In this plasma membrane preparation,
CLC-3 was strongly expressed (Figure 5B).
To directly visualize CLC-3 localization on plasma
membranes, we performed immunoelectron microscopy
Neuron
326Figure 5. CLC-3 Is Present on Plasma Membranes of Neurons at the Synaptic Sites
(A) Primary cultured neurons were surface biotinylated with membrane impermeable, thiol-cleavable NHS-LC-LC-Biotin, lysed in RIPA buffer,
and incubated with streptavidin-coated agarose beads. Surface-biotinylated proteins were eluted from the beads, separated by SDS-PAGE,
and detected on the western blot by anti-CLC-3730–744. PBS was used as a negative control.
(B) Western blot of synaptic vesicles (SV) and synaptosomal membranes (SM) obtained as previously described (Huttner et al., 1983). Na+-K+
ATPase and synaptotagmin were used as known standards to demonstrate the enrichment of fractions of synaptic plasma membranes and syn-
aptic vesicles, respectively.
(C) Electron micrograph of postembedding double-immunogold staining of a lysed synaptosome (25,0003magnification) with anti-CLC-3730–744
and anti-PSD-95 (a postsynaptic marker) followed by detection with corresponding secondary antibody coupled to gold particles of 15 nm size in
case of CLC-3 and 10 nm size in case of PSD-95. The inset boxes show that CLC-3 can be found on the same structure as PSD-95, the post-
synapse.
(D) Control staining with mouse and rabbit IgG followed by the same secondary gold-conjugated antibodies.of lysed synaptic plasma membranes. Synaptic plasma
membranes exhibited marked PSD-95 immunoreactiv-
ity, a component of the postsynaptic density. Immuno-
gold staining of these PSD-95-immunoreactive synapto-
somes for CLC-3 revealed CLC-3 immunoreactivity of
the same structures (Figure 5C), demonstrating CLC-3
localization to postsynaptic plasma membranes. Stain-
ing with preimmune IgG did not demonstrate labeling
(Figure 5D).
CLC-3 Is Expressed at Postsynaptic Sites
Having obtained electron microscopic evidence that
CLC-3 localizes to postsynaptic membranes in synapto-
somal membrane preparations, we asked whether
CLC-3 localization on the plasma membrane is similarly
restricted to synapses in intact neurons. We employed
an antibody to an extracellular domain of CLC-3 (CLC-
3Ex; Wang et al., 2003) and stained neurons prior to per-
meabilization. Under these conditions of extracellular
staining, CLC-3 immunoreactivity was sparse and punc-
tate, primarily staining dendrites, although somal puncta
were also visible. To assess whether these immunoreac-
tive puncta colocalized with synapses, we performed
confocal imaging of neurons that had been double im-
munostained for extracellular CLC-3 and either PSD-95(Figure 6A) or NMDAR1 (Figure 6B). Confocal imaging
of these staining patterns revealed remarkable colocal-
ization, especially in neurites, indicating localization of
CLC-3 at synapses.
Because CLC-3 colocalized with postsynaptic pro-
teins and with postsynaptic plasma membranes, we as-
sessed whether CLC-3 was physically associated with
postsynaptic proteins. Physical association was deter-
mined using coimmunoprecipitation. CLC-3 was first
immunoprecipitated from purified, lysed synaptosomal
plasma membranes free of synaptic vesicles. The immu-
noprecipitates were then probed for the presence of
postsynaptic proteins. CLC-3 immunoprecipitates dem-
onstrated clear immunoreactivity for PSD-95, NMDAR1,
and NMDAR2B (Figure 6C). Immunoprecipitates of PSD-
95 similarly demonstrated CLC-3 immunoreactivity. Im-
portantly, Na+-K+ ATPase a1, a key extrasynaptic com-
ponent of postsynaptic plasma membranes, was not
found in CLC-3 immunoprecipitates (Figure 6C); in like
fashion, immunoprecipitates of Na+-K+ ATPase a1 con-
tained no CLC-3 immunoreactivity. These control exper-
iments demonstrate specificity of the coimmunoprecipi-
tation procedure for synaptic proteins. Taken together,
the colocalization of CLC-3 with postsynaptic proteins
and the coimmunoprecipitation of CLC-3 and the same
CLC-3 and Neuronal Excitability
327Figure 6. Colocalization of CLC-3 with PSD-95 and NR1 as Detected
by Immunofluorescence Microscopy and Immunoprecipitation
(A) Immunocytochemistry showing colocalization of PSD-95 and
CLC-3 as detected by corresponding antibodies followed by fluo-
rescently tagged secondary antibodies (see Experimental Proce-
dures) in isolated rat hippocampal neurons. Anti-CLC-3Ex (Wang
et al., 2003) binds to the extracellular region of CLC-3 and therefore
only recognizes the membrane population of CLC-3 and not the in-
tracellular vesicular fraction. The overlay image shows colocaliza-
tion of CLC-3 and PSD-95 at the synaptic plasma membrane.
(B) Immunofluorescent staining with anti-NR1 and anti-CLC-3Ex
demonstrates colocalization of NR1 (a postsynaptic plasma mem-
brane protein) and CLC-3 at the plasma membrane of rat hippocam-
pal neurons at the synaptic sites.
(C) Association of CLC-3 with PSD-95 and NMDAR 1/2B. CLC-3 was
immunoprecipitated from synaptosomal membrane preparations,
and proteins were resolved by SDS-PAGE. Immunoblotting was per-
formed with anti-PSD-95, anti-NR2B, and anti-NR1 (see Experimen-
tal Procedures) (1, 2, 4). In order to evaluate the specificity of CLC-3
interaction with the postsynaptic proteins, coimmunoprecipitation
was also performed using antibodies against the nonsynaptic pro-
tein, Na+-K+ ATPase a1 (6). Coimmunoprecipitation was also per-
formed in a reciprocal way: anti-PSD-95 and anti-Na+-K+ ATPase
a1 were used to pull down CLC-3 that was detected on the blotpostsynaptic proteins indicate that CLC-3 is located
at postsynaptic sites. It is likely that the interaction of
CLC-3 with PSD-95 and NMDA receptor subunits is me-
diated indirectly through interactions within the PSD.
CLC-3 Expression Decreases the Time Course
of Spontaneous EPSP Decay
Having determined the Cl dependence of NMDA recep-
tor potentials and currents, we assessed the contribu-
tion made by CLC-3 to NMDA receptor-mediated
mEPSPs in immature (P5) neurons. In order to preserve
native intracellular Cl concentrations, we used the perfo-
rated patch technique and compared mEPSP ampli-
tudes and kinetics in hippocampal neurons cultured
from WT and clc-32/2 mice. mEPSPs were primarily
sensitive to MK-801 (10 mM), leaving occasional fast-
inactivating, CNQX-sensitive mEPSPs (Figure 7A).
These data indicate that the majority of mEPSPs were
mediated by NMDA receptor activation.
In neurons from WT mice, the mean decay time con-
stant was 24.6 6 2.8 ms (429 mEPSPs in five neurons),
almost twice the length of the time constant observed
in neurons from clc-32/2 mice (13.6 6 1.4 mS; 1526
mEPSPs from seven neurons, p < 0.01; Figures 7B and
7C). The severely shortened mEPSP decay time con-
stant in clc-32/2 mice confirms that, in immature neu-
rons, CLC-3 channels increase the time the postsynap-
tic membrane remains depolarized during excitatory
synaptic activity, increasing synaptic strength. Neurons
from clc-32/2 mice also exhibited significantly smaller
mean mEPSP amplitudes (1.39 6 0.02 mV, n = 1616
from eight neurons) versus WT (2.27 6 0.07 mV, n =
339 from five neurons, p < 0.001), and a cumulative event
histogram that was significantly left-shifted as com-
pared with the histogram from WT mice (Figure 7D).
In order to determine whether the differences in
mEPSP amplitude and kinetics could be accounted for
by the difference in dendritic development in WT and
clc-32/2 neurons, we compared dendrite development
in P5 WT and clc-32/2 neurons at 6 days in vitro. We
visualized dendrites using MAP2 immunostaining.
Lengths of first-, second-, and third-order dendrites
were traced and measured by an investigator unaware
of genotype. Statistical testing revealed a significant
dependence of dendrite length on dendrite order (p <
0.001), such that first-order dendrites > second-order
dendrites > third-order dendrites. However, there was
no significant difference between dendrite lengths be-
tween WT and KO mice (p = 0.1, n = 206 dendrites WT,
144 dendrites KO). These data are submitted as
Figure S2. Thus, while, in principle, the differences in
EPSP amplitude and decay time could be due to poten-
tial dendritic filtering effect, in fact, we found that there
was no difference in dendrite length between clc-32/2
and WT mice.
with anti-CLC-3 (3, 5). CLC-3 did not associate with Na+-K+ ATPase
a1, which is found in the synaptosomal membrane fraction and was
used as a marker of the plasma membrane to confirm enrichment of
the fraction. Samples taken before immunoprecipitation (Pre-IP)
were detected with both antibodies to demonstrate the presence
of both proteins.
Neuron
328Figure 7. Loss of CLC-3 Expression Reduces
mEPSP Decay Time and Decreases Quantal
Content
Recordings of spontaneous mEPSPs were
made in current clamp mode using the gram-
icidin perforated-patch technique. Resting
potential in these cells was between 255
and 260 mV. Events were detected and ana-
lyzed using the minianalysis feature of the
Synaptosoft program.
(A) Current clamp recordings of mEPSPs
from hippocampal P5 neurons are inhibited
in the presence of MK-801 (10 mM) leaving oc-
casional fast inactivating CNQX-sensitive
mEPSPs. The frequency of events detected
under each pharmacological condition is
given to the right of the voltage traces.
(B) Overlay of multiple events detected in a
single neuron isolated from WT and clc-32/2
mice. Events were homogenous in their rise
times and decay time constants and there-
fore further comparative analysis was per-
formed on averaged events from single cells.
A comparison of the averaged events from
single WT and clc-32/2 cells is shown to the
right. Cells were maintained in culture from
4 to 5 days prior to recording.
(C) Averaged events from individual cells
were well fit with a single exponential (dotted
red line superimposed over the voltage decay
data).
(D) Cumulative amplitude histogram of
mEPSPs pooled from five WT (closed
squares) cells and eight clc-32/2 (open cir-
cles) cells. There was a significant left shift
in the distribution of the two amplitude popu-
lations as seen in the mean average ampli-
tude summary to the right (p < 0.001).CLC-3 Channels Increase EPSP Time Course and
Amplitude via a Ca2+-Dependent Feedback Loop
Because CLC-3 channels are activated by changes in in-
tracellular Ca2+ indirectly, via Ca2+-sensitive CaMKII,
blocking NMDA receptor activation-induced [Ca2+]i in-
creases should prevent CaMKII-induced activation of
CLC-3. Hence, a high affinity intracellular Ca2+ chelator
should alter mEPSP decay kinetics in a manner similar
to that seen in clc-32/2 neurons. Accordingly, we re-
corded mEPSPs in cultured P5 mouse hippocampal
neurons in the presence and absence of BAPTA
(10 mM). We used apamin (100 nM) to eliminate the con-
founding effect of small conductance Ca2+-activated K+
(SK) channel activity on mEPSP amplitude (Faber et al.,
2005; Ngo-Anh et al., 2005). Whole-cell recordings were
made using pipette solutions containing 40 mM Cl2.
In WT, untreated neurons, the mean EPSP amplitude
was 1.39 6 0.02 mV (2002 mEPSPs from five neurons),
significantly larger than the mean amplitude observed
in neurons from clc-32/2 mice (0.708 6 0.009 mV, n =
1668 from 10 neurons). Addition of BAPTA to the pipette
in WT neurons reduced mEPSP amplitude to the same
extent as the clc-32/2 mice (0.704 6 0.005 mV, n =
6412 from six neurons). In clc-32/2 mice, BAPTA had
no effect on mEPSP amplitude (0.760 6 0.007 mV, n =
3851 from 10 neurons).
Similarly, the mean mEPSP decay time constant in
WT, untreated neurons was 33.286 1.68 ms (n = 5), sig-
nificantly longer than that observed in clc-32/2 mice(13.37 6 0.60 ms, n =10). Addition of BAPTA to WT neu-
rons similarly decreased the mean mEPSP decay time
constant to the same extent as the clc-32/2 mice
(16.25 6 0.19 ms, n = 6). BAPTA treatment of clc-32/2
neurons somewhat increased mEPSP decay time over
untreated neurons (clc-32/2 13.37 6 0.60 ms, n = 10;
clc-32/2 plus BAPTA 27.52 6 0.47 ms, n = 10), but
remained significantly decreased compared with un-
treated WT neurons (p < 0.05) . Accordingly, the Ca2+
dependence of NMDA receptor-mediated mEPSP
amplitude and decay time constant is consistent with
modulation of EPSP kinetics by CLC-3 activity. It also
provides functional evidence of close spatial coupling
between CLC-3 channels and NMDA receptors.
Discussion
The central finding of this work is that voltage-activated
Cl2 channels on the postsynaptic plasma membrane al-
ter the excitability of immature hippocampal neurons.
No voltage-activated Cl2 channel has been previously
reported to alter neuronal excitability. NMDA receptor-
induced Ca2+ influx activates CaMKII, opening CaMKII-
activated CLC-3 channels. Because [Cl2]i is higher
than its electrochemical equilibrium at this stage of
postnatal development (Ben-Ari, 2002; Lu et al., 1999;
Stein et al., 2004), opening of CLC-3 channels would
be predicted to depolarize the membrane, prolong-
ing the NMDA-mediated EPSP. In fact, our data
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upon CLC-3 activation. Hence, prior to the developmen-
tal upregulation of KCC2 expression (Ben-Ari, 2002) and
the resultant decrease in [Cl2]i to below its electrochem-
ical equilibrium, neuronal CLC-3 channels amplify the
excitability increase of NMDA receptor activation.
To identify this anion conductance electrophysiologi-
cally, we used solutions that ensured that Cl2 was the
primary charge carrier. The dependence of this out-
wardly rectifying, noninactivating conductance on
CaMKII for activation, together with its inhibition by
both the specific peptide CaMKII inhibitor and the Cl2
channel inhibitor DIDS exactly match the properties of
recombinant CLC-3 (Huang et al., 2001; Robinson
et al., 2004), the only reported CaMKII-activated con-
ductance (anion or cation). The absence of this neuronal
conductance in clc-32/2mice, but not in otherwise iden-
tical WT mice, conclusively identifies this conductance
as CLC-3.
CLC-3, a member of the CLC family of voltage-acti-
vated Cl2 channels, is strongly expressed in brain. We
obtained electrophysiological, biochemical, immuno-
histochemical, and electron microscopic evidence of
CLC-3 localization to the neuronal plasma membrane.
First, whole-cell patch clamp studies demonstrated
a CLC-3-mediated anion conductance on the neuronal
membrane. Next, cell surface proteins isolated with ex-
tracellular biotinylation exhibited CLC-3 immunoreactiv-
ity. Finally, lysed synaptosomal membranes, a synaptic
plasma membrane preparation that we have demon-
strated, by the absence of synaptotagmin immunoreac-
tivity, to be free of synaptic vesicles, also demonstrates
CLC-3 immunoreactivity. Taken together, these data
demonstrate that CLC-3 is present on the neuronal
plasma membrane and is present on synaptic plasma
membranes. Previous studies of the effect of knocking
out CLC-3 on membrane Cl2 currents have been limited
to finding no differences in swelling-induced Cl2 cur-
rents between cells from WT and clc-32/2 mice (Sto-
brawa et al., 2001). Taking advantage of CLC-3’s unique
activation by CaMKII, we have demonstrated not only
the plasma membrane localization of CLC-3, but also
the role of CLC-3 in modulating neuronal excitability.
There is ample evidence that voltage-activated Cl2
conductances contribute to the genesis of the mem-
brane potential (Madison et al., 1986; Sacchi et al.,
1999; Staley, 1995). By extension, such Cl2 conduc-
tances have been assumed to be able to modulate
neuronal excitability. However, the molecular identity,
localization, and mechanisms of activation of these con-
ductances have remained unclear. The identification of
CLC-3 as a modulator of neuronal excitability identifies
a new role for a class of channels previously believed
to function as passive regulators of Cl2 concentration.
Calcium-dependent Cl2 conductances have been char-
acterized as contributing to slow after-depolarization
following spike trains (Currie et al., 1995) and as
being activated following axotomy (Sanchez-Vives and
Gallego, 1994). Single-channel recordings of these
conductances in cultured rat hippocampal and cortical
neurons have found these conductances to be constitu-
tively active and to demonstrate states consistent with a
single pore (Blatz, 1991; Franciolini and Nonner, 1987).
In contrast, our single-channel recordings of CLC-3conductance demonstrated two-pore behavior, consis-
tent with previous studies of single-channel activity for
members of the CLC anion channel family.
The striking colocalization of the synaptic markers
PSD-95 and NMDAR1 with CLC-3 by confocal micros-
copy provides additional evidence of synaptic localiza-
tion of CLC-3 in intact hippocampal neurons. By using
an antibody to an extracellular epitope of CLC-3 and ap-
plying it to living, intact neurons, we restricted antibody
binding to plasma membrane-resident CLC-3. Because
light microscopy cannot distinguish between CLC-3 lo-
calization at the presynaptic or postsynaptic membrane,
we performed double, gold-tagged immunohistochem-
istry of PSD-95 and CLC-3 on lysed synaptic mem-
branes and imaged staining patterns with electron
microscopy. Our finding of PSD-95 and CLC-3 immuno-
reactivity on the same membranes demonstrates (1) the
postsynaptic nature of the membranes and (2) the local-
ization of CLC-3 to these postsynaptic plasma mem-
branes. Furthermore, our finding of PSD-95 and
NMDAR1 immunoreactivity in CLC-3 proteins immuno-
precipitated from lysed synaptic membranes further
supports the notion that CLC-3 is localized to postsyn-
aptic sites and, in particular, to the postsynaptic density.
CLC-3 has been also well documented to be on syn-
aptic vesicles (Stobrawa et al., 2001). Functionally, stud-
ies employing clc-32/2 mice have identified a role for
CLC-3 in Cl2-mediated acidification of synaptic vesicles
and subsequent uptake of glutamate. In our studies of
mEPSPs in clc-32/2 and WT mice, we also observed
a left-shifted cumulative event histogram in clc-32/2
neurons. However, the similarity of the decrease in
mEPSP amplitude seen in BAPTA-treated WT neurons
and clc-32/2 neurons strongly suggests that the dif-
ferences in EPSPs between KO and WT mice are post-
synaptic in origin. The localization of CLC-3 to the post-
synaptic side of NMDAergic synapses suggested that
CLC-3 modulates NMDA-mediated mEPSPs. mEPSPs
from the clc-32/2 neurons had a significantly shorter
time course than that observed in the neurons from
the WT animals at the same age and membrane poten-
tial. Importantly, the absence of significant differences
in steady-state membrane resistance and capacitance
between the WT and clc-32/2 neurons support the ob-
servation that the difference in membrane time con-
stants between clc-32/2 and WT neurons was minimal.
Thus, the greater time constants of mEPSP decay we
observed in neurons from WT mice compared with
those from clc-32/2 mice is inconsistent with the de-
creased input resistance that accompanies the activa-
tion of the CLC-3 conductance. Instead, our data dem-
onstrate that CLC-3 activation in these developing
neurons prolongs synaptically activated NMDA-acti-
vated mEPSPs. This conclusion is further reinforced by
our mEPSP recordings comparing clc-32/2 and clc-3+/+
neurons in the presence of BAPTA: blockade of CaMKII
with BAPTA in the patch pipette resulted in similar
decreases in mEPSP amplitude and time constant of
decay, an effect that cannot be due to modulation of
the presynaptic neuron.
How might CLC-3 activation at synapses prolong
NMDA receptor-activated mEPSPs at this early devel-
opmental stage? Taken together, our data support
a model (Figure 8B) in which Ca2+ entry across the
Neuron
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CLC-3. However, whether CLC-3-induced membrane
depolarization reduces Mg2+ block of NMDA receptors
or whether CLC-3 current itself is sufficient to induce
depolarization is not apparent. In any case, the increase
in the time course in mEPSP decay may enhance synap-
tic efficacy in generating action potentials and in induc-




Five-day-old (P5) Sprague Dawley rats and day 18 embryonic (E18)
rat fetuses from timed pregnancies were used. For knockout stud-
ies, we used P5 clc-32/2 mice (Dickerson et al., 2002) and C57Bl/
6J-SV129 background and littermate WT mice as controls. For gen-
otyping, genomic DNA was extracted from the tails of P5 pups at the
time of culture using REDExtract-N-Amp Tissue PCR Kit (Sigma).
Genotyping was performed by PCR using primers specific for
the WT allele (forward, 50-TACATGTTGCCTGCTGCTGT-30; reverse,
50-CTGCAGCACTCAACTCCAGA-30) and primers specific for the
knockout allele (forward, 50-TGAATGAACTGCAGGACGAG-30; re-
verse, 50-ATACTTTCTCGGCAGGAGCA-30; Dickerson et al., 2002).
Thirty-five cycles of PCR were performed at following conditions:
denaturation at 94C for 2 min, annealing at 57C for 30 s, extension
at 68C for 1 min.
Antibodies
Anti-CLC-3 was produced (Quality Controlled Biochemicals) from
a synthetic peptide corresponding to amino acids 730–744 of hu-
man CLC-3, with an additional alanine and glutamic acid
Figure 8. NMDA-Mediated Ca2+ Influx Activates CLC-3
(A) Spontaneous EPSPs were recorded from mouse hippocampal
P5 neurons under control conditions and in the presence of BAPTA
(10 mM) in the pipette solution. Data were obtained in whole-cell cur-
rent-clamp recordings. Averaged events from representative single
cells are overlaid for comparison.
(B) Mean mEPSP amplitudes in WT and clc-32/2 mice in the pres-
ence and absence of BAPTA (10 mM).
(C) Mean mEPSP decay time constants in WT and clc-32/2 mice in
the presence and absence of BAPTA. Decay time course was well
fit with a single exponential function.
(D) Model for the activation of CLC-3 as a function of NMDA receptor
opening in the postsynaptic membrane. Numbers correspond to the
sequence of events leading to CLC-3 activation.(GSSRVCFAQHTPSLPAE). Specificity of the antibody for CLC-3
has been previously reported (Huang et al., 2005). Dr. Joseph R.
Hume kindly provided the affinity purified, polyclonal antibody to
an extracellular loop of a transmembrane portion of CLC-3 (Wang
et al., 2003). The mouse monoclonal anti-NMDAR1 was obtained
from Chemicon. The mouse anti-PSD-95 was from Affinity Biore-
agents. Anti-Na-K ATPase a was obtained from Upstate and anti-
synaptotagmin from BD Biosciences. Alexa 488-conjugated goat
anti-rabbit and rhodamine-conjugated goat anti-mouse IgG were
from Molecular Probes-Invitrogen. Rhodamine-conjugated rabbit
anti-sheep IgG was from ICN. Horseradish peroxidase-conjugated
goat anti-mouse IgG and donkey anti-rabbit IgG were from Promega
and Amersham, respectively. Goat anti-rabbit and goat anti-mouse
IgG conjugated to 15 nm and 10 nm gold particles, respectively,
were obtained from Ted Pella.
Neuronal Cultures
We have previously used hippocampal neurons cultured from E17–
P30 animals as a model of postnatal development (Marks et al.,
2005; Marks et al., 2000). Briefly, isoflurane-anesthetized rats or
mice were decapitated, the hippocampi removed, sectioned
(400 mM), and incubated in oxygenated, pH-buffered saline. Sec-
tions were incubated at room temperature with papain for 30 min
then protease (0.4 mg/ml) for 15 min. Slices were placed into a micro-
centrifuge tube containing 1 ml Hybernate A and mechanically
triturated with a series of 2–4 fire-polished Pasteur pipettes with pro-
gressively decreasing mouth diameters. Dissociated cells were
centrifuged through an iodixanol density gradient (1.055–1.026 g/
ml) at 1900 rpm for 15 min, and the resultant pellet suspended in
the most inferior aqueous fraction. DNase (175 U/ml) was added to
facilitate dispersion, and 200 ml aliquots plated onto poly-lysine-
coated coverslips. Coverslips were placed on a layer of cultured
cortical astrocytes, maintained in DMEM supplemented with 4-(2-
hydroxyethyl)-1-piperazine-ethanesulfonic acid HEPES, 15 mM,
N2, and ovalbumin. Cells were incubated in a humidified atmosphere
containing O2 (5% 6 0.1%) and CO2 (5% 6 0.1%), balance N2 at
32C by means of a servo-controlled tri-gas incubator (Hereus) con-
nected to CO2 and O2 tanks. The O2 partial pressure in the incubator
was continuously measured with a Clarke electrode and the O2 and
CO2 set points maintained by flushing the incubator with N2 and
CO2, respectively. For experiments employing clc-3
2/2 mice, geno-
typic purity of the cultures was ensured by separately dissociating
and culturing hippocampi from individual identified pups. Immuno-
staining for the neuron-specific marker NeuN, as well as for oligo-
dendrocyte- and astrocyte-specific markers, demonstrated that
these cultures contained >98% neurons (data not shown).
Electrophysiology
Whole-Cell Voltage-Clamp Recordings
Patch-clamp recordings from cultured hippocampal neurons were
made using quartz pipettes and an EPC-9 amplifier (HEKA Elektro-
nik). Extra- and intracellular solutions were designed such that Cl2
was the primary charge carrier. The bath solution contained
140 mM HCl, 140 mM N-methyl D-glucamine, 2 mM CaCl2, 1 mM
MgCl2, and 10 mM HEPES (pH 7.4). The pipette solution contained
40 mM HCl, 100 mM L-glutamic acid, 140 mM N-methyl D-gluc-
amine, 0.2 mM CaCl2, 2 mM MgCl2, 1 mM EGTA, 10 mM HEPES,
and 2 mM ATP-Mg (pH 7.2). Free Ca2+ was calculated to be 40 nM.
Ca2+-independent, autonomously active, autophosphorylated
CaMKII was prepared daily from purified rat brain CaMKII as previ-
ously described (Huang et al., 2001) and introduced into the cell
via the patch pipette. The Cl2 equilibrium potential was calculated
to be231 mV. Under these ionic conditions, nonspecific leak current
was identified as a depolarizing shift in reversal potential. Currents
were elicited using a series of test pulses from 2110 to +110 mV in
10 mV increments from a holding potential of 240 mV. Test pulses
(200 ms) were delivered at 2 s intervals. Current recordings were ac-
quired at 2 kHz and filtered at 1 kHz. To induce fast internal Ca2+
buffering, 10 mM BAPTA was, in some experiments, substituted
for EGTA, and the CaCl2 removed. In these experiments, the pipette
solution contained 104 mM K+ methanesulfonate, 26 mM KCl, 10 mM
NaCl, 2 mM MgCl2, 10 mM BAPTA 10, 10 mM HEPES, and 3.5 mM
Mg2-ATP (pH 7.2). The external solution contained 136 mM NaCl,
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1.3 mM MgCl2 (pH 7.4).
Recordings of Spontaneous Postsynaptic Potentials
In neurons from KO and WT mice, spontaneous mEPSPs were ac-
quired in the perforated patch configuration using 50 mg/ml gramici-
din (Sigma) in a pipette solution containing 150 mM KCl and 10 mM
HEPES (pH 7.4). In experiments where either [Cl2]i. was set or where
cell-impermeant constituents (AIP or BAPTA) were introduced,
whole-cell recordings were made. The bath solution in these exper-
iments contained 136 mM NaCl, 2.5 mM KCl, 10 mM HEPES, 10 mM
D-glucose, 2 mM CaCl2, 1.3 mM MgCl2, 0.5 mM tetrodotoxin, and
100 mM picrotoxin (pH 7.4). In some experiments (see text), small
conductance Ca2+-activated K+ channels were blocked with apamin
(100 nM). Brief, negative 10 mV voltage steps were repeatedly ap-
plied to monitor changes in input resistance and capacitance for
15–20 min. Spontaneous mEPSP recordings were acquired and
stored digitally using the data acquisition/analysis package PULSE
(HEKA Electronik). Potential recordings were acquired at 6 kHz
and filtered at 3 kHz. We used MiniAnalysis 6 (Synaptosoft) to detect
mEPSP events, create cumulative amplitude histograms of the
pooled data, and fit decay times of the events. mEPSPs from single
cells were averaged, and the decay fit with a single exponential.
Single-Channel Recordings
Single-channel recordings were made using inside-out patches. The
pipette solution used in whole patch-clamp experiments was used
as the bath solution in the single-channel studies; however, the
Cl2 concentration in these experiments was elevated to 140 mM.
Similarly, the bath solution used in the whole-cell patch-clamp
experiments (Cl2 140 mM) was used as the pipette solution. The au-
tonomous, autophosphorylated CaMKII was delivered to the inner
surface of the patch using a DAD-12 drug perfusion system
(Adams-List, Westbury, NY). Single channel currents were digitally
sampled at 1.6 kHz and filtered at 800 Hz. Current traces were dis-
played and stored digitally and analyzed offline using the single-
channel analysis program TAC (Bruxton Corp.).
All results are expressed as mean 6 standard error of the mean
(SEM). Student’s t test was used to test for significant differences.
All experiments were performed at room temperature.
Immunocytochemistry
Cells cultured on coverslips were rinsed three times with phosphate-
buffered saline (PBS). Nonspecific binding sites were blocked in
PBS containing goat serum (2%), bovine serum albumin (0.5%),
and sucrose (4%). Living neurons were incubated overnight at 4C
with anti-CLC-3Ex (1:400) then fixed in paraformaldehyde 4% for
30 min at 4C. Neurons were permeabilized with Triton X-100
(0.1%) for 3 min at 4C. After 1 hr blocking, cells were incubated
with mouse monoclonal anti-NMDAR1 (1:1000) or sheep anti-PSD-
95 (1:200). Primary antibody binding was amplified and visualized
with Alexa 488-conjugated goat anti-rabbit antibody (1:2000) for
anti-CLC-3, rhodamine-conjugated goat anti-mouse IgG (1:4000)
for NMDAR1, and rhodamine-conjugated rabbit anti-sheep IgG
(1:2000) for anti-PSD-95. Coverslips were mounted and observed
with a 603, 1.40 NA objective and imaged with a confocal micro-
scope (Fluoview, Olympus).
Surface Biotinylation
Biotinylation of plasma membrane proteins having an extracellular
domain was performed on cultures of hippocampal neurons from
E18 Sprague-Dawley rats, using a water-soluble, membrane imper-
meant, and thiol-cleavable biotin reagent, as described previously
(Davis et al., 1998) with minor modifications. Biotinylation was per-
formed directly in the culture dish. Neuronal cultures were rinsed
with ice-cold PBS (pH 7.4) and incubated with EZ-link Sulfo-NHS-
LC-LC-Biotin (3 mg/ml, Pierce) in PBS containing 0.1 mM CaCl2
and 1mM MgCl2, (pH 8.0) for 30 min at 4
C. Biotinylation was termi-
nated by adding 10mM Tris (Tris(hydroxymethyl)aminomethane) (pH
8.5) for 5 min at 4C, followed by three rinses with PBS containing
Tris, 10 mM to quench unbound biotin. Cells were harvested and
lysed in modified RIPA buffer (50 mM Tris [pH 7.4], 150 mM NaCl,
1% Igepal CA-630, 10 mM NaMoO4) with 0.2% protease inhibitor
cocktail (Sigma) for 1 hr at 4C. The lysate was centrifuged, and
protein concentration was determined in the supernatant by BCA
Assay (Pierce). The lysate was incubated overnight at 4C withStreptavidin-conjugated agarose beads (Sigma), equilibrated with
RIPA buffer containing 1% BSA, and then washed. Proteins were
eluted from the beads by incubating them in a buffer containing
SDS (1%) and dithiothreitol (50 mM) for 5–8 min at 95C. Proteins
were resolved by 7.5% SDS-PAGE, transferred to a polyvinylidene
difluoride (PVDF) membrane (Amersham Biosciences), and incu-
bated in anti-CLC-3730–744 (1:1000). CLC-3 binding was amplified
and visualized using a peroxidase-linked goat anti-rabbit IgG. Blots
were developed using SuperSignal West Dura Extended Duration Kit
(Pierce). To assess nonspecific streptavidin binding, some cultures
were treated identically, except that the biotin was absent.
Isolation of Synaptosomal Membranes
Synaptosomal membranes and synaptic vesicles were isolated as
described elsewhere (Huttner et al., 1983; Thoidis et al., 1998; Wat-
son et al., 1994) with minor modifications. All centrifugations were
carried out at 4C. Hippocampi freshly isolated from adult rats
were homogenized in an ice-cold buffer containing sucrose
(0.3 M), HEPES (10 mM), and protease inhibitor cocktail (1:500,
Sigma) (pH 7.3). Cell debris and nuclei were pelleted by centrifuga-
tion at 1000 3 g. The supernatant was centrifuged at 10,000 3 g
for 15 min, resulting in a pellet with two visible layers. The synapto-
some-rich upper layer was isolated by gentle resuspension-centrifu-
gation in buffered sucrose containing protease inhibitors, then di-
luted with nine volumes of ice-cold H2O (hypotonic lysis in order to
release synaptic vesicles from synaptosomes) and immediately ho-
mogenized with three strokes in a homogenizer. To this homoge-
nate, 1 M HEPES (pH 7.4) was added to a final concentration of
7.5 mM and incubated on ice for 30 min to ensure synaptosome
lysis. The lysate was centrifuged at 25,000 3 g for 20 min, yielding
a supernatant containing synaptic vesicles and a pellet containing
lysed synaptosomal membranes. The supernatant was centrifuged
at 165,0003 g for 2 hr. The resultant pellet containing synaptic ves-
icles was suspended in 10 mM HEPES with protease inhibitor cock-
tail (1:1000) and frozen at 280C until use.
To isolate synaptic membranes, the pellet containing crude lysed
synaptosomal membranes was suspended in homogenization
buffer, layered on top of a three-step discontinuous sucrose gradi-
ent (0.8–1.0–1.2 M), and centrifuged at w150,000 3 g for 2 hr in
a swinging-bucket rotor. Purified synaptosomal membranes were
found in the interface between 1.0 and 1.2 M sucrose. The sucrose
concentration was diluted to 0.3 M using HEPES (10 mM), and the
synaptosomal membranes centrifuged at 150,000 3 g for 45 min.
The resulting pellet was resuspended in HEPES (10 mM) with prote-
ase inhibitors at 1:1000 and stored at 280C until use.
Double Immunogold Staining and Electron Microscopy
Preparations of lysed synaptosomal membranes were fixed with
0.15% glutaraldehyde and 4% paraformaldehyde for 1 hr at 4C,
washed with PBS, and embedded in LR white resin (Electron Micros-
copy Science) at 45C in a vacuum oven for 48 hr. Preparations were
sectioned (90 nm) with a Reichert-Jung Ultracut E microtome. Sec-
tions were stained with anti-CLC-3730-744 (1:100) and mouse mono-
clonal antibody against postsynaptic marker PSD-95 (1:20). Preim-
mune rabbit and mouse IgG (Sigma) was used as a negative
control. CLC-3 and PSD-95 were visualized using goat anti-rabbit
and goat anti-mouse antibodies conjugated to 15 nm and 10 nm
gold particles, respectively. Images were captured using a Tecnai
F30 transmission electron microscope (TEI).
Western Blot of Hippocampal Preparations
Preparations of lysed synaptosomes and synaptic vesicles were sol-
ubilized in SDS sample buffer. Aliquots were taken for protein deter-
mination by BCA assay (Pierce), after which dithiothreitol (DTT;
50 mM) was added. Samples were heated at 65C for 15 min and
centrifuged at 14,000 3 g for 3 min. Proteins in the supernatant
were resolved by SDS-PAGE and transferred to a PVDF membrane.
Blots were incubated for 1 hr at room temperature or overnight at
4C with anti-CLC-3730-744 (1:1000), anti-Na-K ATPase a (1:1000),
or anti-synaptotagmin (1:1000). Binding was amplified with either
goat anti-mouse (Promega) or donkey anti-rabbit (Amersham) sec-
ondary antibodies conjugated to horseradish peroxidase. Preim-
mune rabbit or mouse IgG (Sigma) was used as a negative control.
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Duration Substrate (Pierce).
Coimmunoprecipitation from Synaptosomal Membranes
Preparations of lysed synaptosomal membranes were incubated in
RIPA buffer (50 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100, 1%
NP-40, 0.1% SDS, and 1 mM EDTA) containing protease inhibitors
at 4C for 40 min, then centrifuged at 14,000 3 g for 15 min. The su-
pernatant was collected and precleared by incubation with Protein A
agarose beads (Sigma) for 30 min. Proteins were incubated with
anti-CLC-3730–744 followed by incubation with Protein A agarose
beads (Sigma). Beads were pelleted by centrifugation. Proteins
bound to the beads were eluted by incubation in SDS/DTT sample
buffer for 3 min at 95C. The eluate (IP) and pre-IP samples were sep-
arated by SDS-PAGE with following transfer to PVDF membranes.
The membrane was immunoblotted with anti-CLC-3730–744, anti-
NR1 (1:200), anti-NR2B (1:1000), anti-PSD-95 (1:1000), or anti-
Na+-K+ ATPase (1:1000).
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/52/2/321/DC1/.
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